Delivery Order HHSO100201500008I-HHSO10033001T
Award Date
7/28/16
Potential Completion Date
1/31/19
Potential Value
$2.1M
Awardee
University Of Illinois
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Chicago, IL 60612, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $6,750,034.00 cost-reimbursement delivery order contract to the University of Illinois, doing business as The Board of Trustees of the University of Illinois. This contract is a task order under the Biomedical Advanced Research and Development Authority (BARDA) Chemical and Radiological/Nuclear Animal Model contract vehicle established in 2015-2020. The contract has no...
This federal contract award to the University of Illinois, doing business as The Board of Trustees of the University of Illinois, is for the "RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])" project. The contract has a ceiling value of $2,559,039.84 and is a Cost Plus Fixed Fee Delivery Order awarded by the Office of the Assistant Secretary for...
This is a definitive contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to the University of Illinois for preclinical pharmacology and toxicology studies. The contract, valued at $24,207,156.38, does not have a set-aside designation. The University of Illinois, a major public research institution, is conducting research and development work to support the PREVENT Cancer Preclinical Drug Development Program, a structured...
This federal contract award is a definitive contract between the University of Illinois, doing business as The Board of Trustees of the University of Illinois, and the U.S. government. The contract has a potential value of $200,000.00 and was awarded on May 15, 2001, with a completion date of December 31, 2006. The contract does not have a set-aside designation. The University of Illinois is a major public research university system that has performed a wide range of research and development...
This federal contract award, valued at $149,395.10, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Illinois, a major public research university system. The contract is for professional and consulting services and does not have a set-aside designation. The University of Illinois has been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract from the National Cancer Institute, valued at $149,995,000, to support the PREVENT Cancer Preclinical...
This federal contract award was issued by the National Cancer Institute, a civilian agency under the U.S. Department of Health and Human Services, to the University of Illinois for a "CONTRACT ORIENTATION AND KICKOFF MEETING" from September 30, 2015 to December 31, 2015. The award, which has a ceiling value of $2,587.19, is a delivery order under the PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) indefinite delivery/indefinite quantity (IDIQ) contract. The contract has a...
The University of Illinois, doing business as The Board of Trustees of the University of Illinois, was awarded a $1,541,566.00 Definitive Contract by a U.S. government agency. The contract does not have a set-aside designation and is a Cost No Fee type. The University of Illinois is performing the contract work in Illinois, USA, which involves providing a range of research, products, and services to the federal government. The University of Illinois is a major public research university that has...
This is a delivery order award under the National Cancer Institute's "PREVENT Toxicology and Pharmacology Testing (PREVENT TOX)" indefinite delivery contract. The $2,273,213.36 task order was awarded to the University of Illinois to conduct research on "A Dual AKT/PDPK1 Inhibitor for Actinic Keratosis and Skin Cancer Prevention in Immunocompromised Individuals". This work is part of the National Cancer Institute's "Preclinical Prevent Cancer Program: Toxicology and...
This $2,325,040.00 federal contract award was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to the Illinois Institute of Technology Research Institute (IITRI), a non-profit organization. The contract is a Delivery Order under the Biomedical Advanced Research and Development Authority (BARDA) Animal Model Development 2011-2016 indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract supports the Major Program Code for...
This federal contract award was made by the National Cancer Institute (NCI), a civilian agency, to the University of Illinois. The contract, valued at $1,931,792.00, supports the clinical development of an HPV16L1/RG1 chimeric virus-like particle vaccine under the NCI's PRECLINICAL PREVENT TOXICOLOGY AND PHARMACOLOGY major program. The contract has a period of performance from September 25, 2015 to December 31, 2021 and does not have a set-aside designation. The University of Illinois is the...